Zou, Weiping
University of Michigan, Ann Arbor,
United States
2025 Rank: 1231
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 32 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1231 | 1237 |
| Total Cites | 5726 | 6080 |
| H-index | 34 | 36 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 119 | 125 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 457 | 473 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 3410 | 3506 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 4834 | 5077 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
5.82%
|
|
Zou, Weiping
University of Michigan Medical School,
United States
2024 Rank: 1120
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 34 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1120 | 1222 |
| Total Cites | 5616 | 5951 |
| H-index | 34 | 34 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 144 | 147 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 471 | 479 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 3249 | 3315 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 4785 | 5047 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
5.63%
|
|
Zou, Weiping
University of Michigan, Ann Arbor,
United States
2023 Rank: 1081
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 37 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1081 | 1130 |
| Total Cites | 5575 | 5935 |
| H-index | 35 | 36 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 142 | 147 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 501 | 512 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 3259 | 3340 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 4662 | 4943 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.20 |
| Self-Citation Percentage |
6.07%
|
|
Zou, Weiping
University of Michigan Medical School,
United States
2022 Rank: 952
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 38 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 952 | 1022 |
| Total Cites | 4942 | 5094 |
| H-index | 34 | 35 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 158 | 164 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 602 | 618 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 2961 | 3041 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 4096 | 4165 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
2.98%
|
|
Zou, Weiping
University of Michigan Medical School,
United States
2021 Rank: 1225
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 37 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1225 | 1360 |
| Total Cites | 6538 | 6765 |
| H-index | 40 | 40 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 252 | 260 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 945 | 966 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 3851 | 3966 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 5395 | 5507 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
3.36%
|
|
Zou, Weiping
University of Michigan, Ann Arbor,
United States
2020 Rank: 1653
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 37 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1653 | 1762 |
| Total Cites | 3530 | 3669 |
| H-index | 32 | 33 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 199 | 203 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 720 | 731 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 2465 | 2520 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 2914 | 2991 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
3.79%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.